| Literature DB >> 30991306 |
Akio Kimura1, Akira Takekoshi2, Nobuaki Yoshikura2, Yuichi Hayashi2, Takayoshi Shimohata2.
Abstract
The clinical features of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy remain to be elucidated. We describe here the clinical features of 14 patients with GFAP astrocytopathy confirmed by detection of GFAP-IgG in cerebrospinal fluid (CSF). The novel findings of this study are as follows. First, over half of the patients presented with movement disorders (tremor, myoclonus, and ataxia), autonomic dysfunction (mainly urinary dysfunction), and hyponatremia. Second, most patients showed transient elevation of adenosine deaminase activity levels in CSF. Finally, some patients showed bilateral hyperintensities in the posterior part of the thalamus on brain magnetic resonance imaging.Entities:
Keywords: Adenosine deaminase activity (ADA); Astrocytopathy; Autoantibody; Glial fibrillary acidic protein (GFAP); Movement disorder
Year: 2019 PMID: 30991306 DOI: 10.1016/j.jneuroim.2019.04.004
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478